Cargando…

The Waveform Fluctuation and the Clinical Factors of the Initial and Sustained Erythropoietic Response to Continuous Erythropoietin Receptor Activator in Hemodialysis Patients

Objectives. Erythropoiesis-stimulating agents (ESA) are the main treatment for anemia in hemodialysis (HD) patients. We evaluated factors determining the response after treatment of a new ESA (continuous erythropoietin erythropoietin receptor activator (CERA)). Methods. 61 HD patients were classifie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Wen-Sheng, Wu, Yueh-Lin, Li, Szu-Yuan, Yang, Wu-Chang, Chen, Tzen-Wen, Lin, Chih-Ching
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Scientific World Journal 2012
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349104/ https://www.ncbi.nlm.nih.gov/pubmed/22619601 http://dx.doi.org/10.1100/2012/157437

Ejemplares similares

The Associations between Erythropoietic Response with Inflammation Markers and Perfluorinated Chemicals in Hemodialysis Patients
por: Liu, Wen-Sheng, et al.
Publicado: (2023)

Erythropoietin and Non-Erythropoietic Derivatives in Cognition
por: Newton, Samuel S., et al.
Publicado: (2021)

Dynamics of Erythropoietic Biomarkers in Response to Treatment With Erythropoietin in Belgrade Rats
por: Nguyen, Ly M., et al.
Publicado: (2018)

Non‐erythropoietic erythropoietin‐derived peptide protects mice from systemic lupus erythematosus
por: Huang, Bo, et al.
Publicado: (2018)

Non-erythropoietic erythropoietin derivatives protect from light-induced and genetic photoreceptor degeneration
por: Colella, Pasqualina, et al.
Publicado: (2011)

Comparison of the acute erythropoietic capacities of erythropoietin and U-74389G in terms of hemoglobin levels
por: Tsompos, Constantinos, et al.
Publicado: (2017)

Determinant Effects of Average Fasting Plasma Glucose on Mortality in Diabetic End-Stage Renal Disease Patients on Maintenance Hemodialysis
por: Lin, Yi-Chun, et al.
Publicado: (2016)

Different effect of hypercholesterolemia on mortality in hemodialysis patients based on coronary artery disease or myocardial infarction
por: Lin, Yi-Chun, et al.
Publicado: (2016)

Garlic Accelerates Red Blood Cell Turnover and Splenic Erythropoietic Gene Expression in Mice: Evidence for Erythropoietin-Independent Erythropoiesis
por: Akgül, Bünyamin, et al.
Publicado: (2010)

Erythropoietic protoporphyria
por: Lecha, Mario, et al.
Publicado: (2009)

Seismic waveform simulation for models with fluctuating interfaces
por: Rao, Ying, et al.
Publicado: (2018)

Negative Relationship between Erythropoietin Dose and Blood Lead Level in Patients Undergoing Maintenance Hemodialysis
por: Huang, Wen-Hung, et al.
Publicado: (2016)

Erythropoietin prevents dementia in hemodialysis patients: a nationwide population-based study
por: Hung, Peir-Haur, et al.
Publicado: (2019)

Erythropoietin Use and the Risk of Stroke in Patients on Hemodialysis: A Retrospective Cohort Study in Taiwan
por: Hung, Peir‐Haur, et al.
Publicado: (2021)

Correction of Anemia with Continuous Erythropoietin Receptor Activator in Korean Patients on Long-Term Hemodialysis
por: Oh, Jieun, et al.
Publicado: (2014)

Microcytosis in Erythropoietic Protoporphyria
por: Graziadei, Giovanna, et al.
Publicado: (2022)

The Association of Erythropoietin and Age-Related Macular Degeneration in Hemodialysis Patients: A Nationwide Population-Based Cohort Study
por: Huang, Evelyn-Jou-Chen, et al.
Publicado: (2022)

Energy Requirement of Patients Undergoing Hemodialysis: A Cross-Sectional Study in Multiple Centers
por: Wu, Pei-Yu, et al.
Publicado: (2020)

Transforming growth factor-β1 decreases erythropoietin production through repressing hypoxia-inducible factor 2α in erythropoietin-producing cells
por: Shih, Hong-Mou, et al.
Publicado: (2021)

Dialysis Membranes Influence Perfluorochemical Concentrations and Liver Function in Patients on Hemodialysis
por: Liu, Wen-Sheng, et al.
Publicado: (2018)

V-J combinations of T-cell receptor predict responses to erythropoietin in end-stage renal disease patients
por: Wong, Henry Sung-Ching, et al.
Publicado: (2017)

Circulating growth arrest-specific protein 6 levels are associated with erythropoietin resistance in hemodialysis patients
por: Chen, Miao-Pei, et al.
Publicado: (2016)

THE ERYTHROPOIETIC ACTION OF GERMANIUM DIOXIDE
por: Hammett, Frederick S., et al.
Publicado: (1922)

Erythrodontia in congenital erythropoietic porphyria
por: Bhavasar, Rashmi, et al.
Publicado: (2011)

Effect Modifying Role of Serum Calcium on Mortality-Predictability of PTH and Alkaline Phosphatase in Hemodialysis Patients: An Investigation Using Data from the Taiwan Renal Registry Data System from 2005 to 2012
por: Lin, Yen-Chung, et al.
Publicado: (2015)

Associations between perfluorinated chemicals and serum biochemical markers and performance status in uremic patients under hemodialysis
por: Liu, Wen-Sheng, et al.
Publicado: (2018)

Evidence in the UK Biobank for the underdiagnosis of erythropoietic protoporphyria
por: Dickey, Amy K., et al.
Publicado: (2020)

DNA SYNTHESIS AND MITOSIS IN ERYTHROPOIETIC CELLS
por: Grasso, Joseph A., et al.
Publicado: (1967)

Congenital Erythropoietic Porphyria with Undescended Testis
por: Arora, Sandeep, et al.
Publicado: (2016)

Erythropoietic Factor in Human Mixed Saliva
por: Sitaramamurti, A.
Publicado: (1941)

The role of ClpX in erythropoietic protoporphyria
por: Whitman, Jared C., et al.
Publicado: (2018)

An Atypical Case of Congenital Erythropoietic Porphyria
por: Sudrié-Arnaud, Bénédicte, et al.
Publicado: (2021)

Hypertrichosis and erythrodontia in congenital erythropoietic porphyria
por: Enciso, Leonardo
Publicado: (2021)

Erythropoietin-producing tubercle granuloma in a hemodialysis patient
por: Satoh, Minoru, et al.
Publicado: (2013)

Obesity may be erythropoietin dose-saving in hemodialysis patients
por: El-Kannishy, Ghada M., et al.
Publicado: (2018)

Erythropoietin treatment and the risk of hip fractures in hemodialysis patients
por: Suresh, Sukanya, et al.
Publicado: (2021)

Effects of Iron Supplementation on Erythropoietic Response in Patients with Cancer-Associated Anemia Treated by Means of Erythropoietic Stimulating Agents
por: Karlsson, Torbjörn
Publicado: (2011)

The essential role of the transporter ABCG2 in the pathophysiology of erythropoietic protoporphyria
por: Wang, Pengcheng, et al.
Publicado: (2019)

Association between Age and Changes in Heart Rate Variability after Hemodialysis in Patients with Diabetes
por: Niu, Sheng-Wen, et al.
Publicado: (2018)

Predicting erythropoietin resistance in hemodialysis patients with type 2 diabetes
por: Schneider, Andreas, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_do85k0qtj3qq6v5qugmm9u7edv